Vir Biotechnology Inc
VIR
NASDAQ
Biotechnology
$9.24
USD
+0.24 (+2.67%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.50B
Volume 1.0M
Revenue
$303.23M
TTM
+1495.9%
YoY
Gross Margin
100%
TTM
+4.1%
YoY
Net Income
$-251.68M
TTM
+54.3%
YoY
Operating Cash Flow
$-202.51M
TTM
+55.7%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 1.2 | 0.2 | 64.1 | -0.0 | 238.9 |
YoY Growth | -60.5% | -89.9% | +417.8% | -101.0% | +19582.5% |
Cost of Revenue | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 1.2 | 0.3 | 64.0 | -0.0 | 238.9 |
Selling, General & Administrative | 22.3 | 22.2 | 23.6 | 23.3 | 30.2 |
Other Operating Expenses | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 119.6 | 173.7 | 112.0 | 132.3 | 165.5 |
Operating Income | -118.4 | -173.4 | -47.9 | -132.3 | 73.5 |
EBITDA | -115.7 | -170.4 | -45.0 | -129.5 | 76.3 |
Other Income / Expense | -3.2 | 1.1 | -2.9 | -0.4 | -2.2 |
Total Other Income / Expense | 7.6 | 10.5 | 4.9 | 6.8 | 6.8 |
Income Before Income Taxes | -110.8 | -163.0 | -43.1 | -125.5 | 80.3 |
Income Taxes | 0.2 | 0.2 | -0.1 | 0.2 | 0.2 |
Net Income | -111.0 | -163.1 | -42.9 | -125.7 | 80.1 |
Consolidated Net Income / Loss | -111.0 | -163.1 | -42.9 | -125.7 | 80.1 |
Net Income Attributable to Common Shareholders | -111.0 | -163.1 | -42.9 | -125.7 | 80.1 |
Basic EPS | -$0.80 | -$1.17 | -$0.31 | -$0.85 | $0.48 |
Diluted EPS | -$0.80 | -$1.17 | -$0.31 | -$0.85 | $0.47 |
Basic Shares Outstanding | 138.4M | 138.9M | 139.2M | 147.4M | 167.7M |
Diluted Shares Outstanding | 138.4M | 138.9M | 139.2M | 147.4M | 168.9M |